http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112618699-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6655263ba4852e71280f7529b0065f3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-33 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 |
| filingDate | 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca5504772efb198d9faae167f4fc606f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe779ff8a5e58c8579d97ddc5b3a9b0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3471c3a49870c2ce210c525bd731782e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c24e1459301e0a938ca5fd6403ed164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fd5ba6e7566d00f6bef5194187b0a02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0203f24b7790eefca2661e4d0a8f12cf |
| publicationDate | 2021-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112618699-A |
| titleOfInvention | A kind of reagent capable of providing therapeutically effective amount of interleukin 10 and its anti-tumor application |
| abstract | The invention discloses a reagent capable of providing a therapeutically effective amount of interleukin 10 and its anti-tumor application, and specifically discloses the use of the reagent capable of providing a therapeutically effective amount of interleukin 10 in the preparation of a medicament for preventing or inhibiting tumors. The agent capable of providing a therapeutically effective amount of interleukin 10 is selected from the group consisting of a therapeutically effective amount of interleukin 10, a drug capable of expressing interleukin 10 in a subject, and a drug capable of stimulating the production of interleukin 10 in a subject. The present invention also provides an interleukin-10 chemically modified messenger ribonucleic acid, the messenger ribonucleic acid has an open reading frame encoding at least one interleukin-10 protein, and the messenger ribonucleic acid has undergone at least one chemical modification. The present invention overcomes technical prejudice and finds that interleukin 10 can be used to inhibit tumors with interleukin 10 receptors, and the chemically modified messenger ribonucleic acid of interleukin 10 provided by the present invention has tumor inhibitory potential. |
| priorityDate | 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 193.